Genomma Lab Internacional... (GNMLF)
Company Description
Genomma Lab Internacional, S.A.B. de C.V., together with its subsidiaries, engages in the development, marketing, and sale of over-the-counter pharmaceutical and personal care products in Mexico and internationally.
It provides skin care, health and wellness, hair care, pain relief, cough and cold, gastro, sexual health, antiperspirant deodorant, hand sanitizer, isotonic deink, and razor products, as well as analgesics, antifungals, and hemorrhoids.
The company offers its products under the Cicatricure, Asepxia, Teatrical, Goicoechea, Sistema GB, Medicasp, Tío Nacho, Vanart, Novamil, Ultra Bengue, X-Ray, Tafirol, Alliviax, Bufferin, Next, XL-3, Genoprazol, QG5, Kaopectate, Proctan, Nikzon, Unesia, Silka Medic, lagicam, Suerox, Groomen, DiabetTX, and other brands.
Genomma Lab Internacional, S.A.B. de C.V. was incorporated in 1996 and is based in Mexico City, Mexico.
| Country | MX |
| IPO Date | May 4, 2012 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| Employees | 1,605 |
| CEO | Juan Marco Sparvieri |
Contact Details
Address: Av. Antonio Dovalí Jaime no.70 Mexico City, DF MX | |
| Website | https://www.genommalab.com |
Stock Details
| Ticker Symbol | GNMLF |
| Exchange | PNK |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | n/a |
| CUSIP Number | n/a |
| ISIN Number | MX01LA010006 |
| Employer ID | - |
| SIC Code | n/a |
Key Executives
| Name | Position |
|---|---|
| Juan Marco Sparvieri | Chief Executive Officer |
| Engineer Antonio Zamora Galland | Executive Vice President of Finance & Administration and Chief Financial Officer |
| Alejandro Bastón Patiño | EVice President of Institutional Relations, Media, HR & Sustainability |
| Christianne Ibáñez Garcia | Head of Investor Relations |
| Daniel Suarez Neria | Investor Relations Officer |
| Efraan Tapia Cardova | Secretary |
| Lic. Rodrigo Alonso Herrera Aspra | Founder & Chairman of the Board |